Journey Strategic Wealth’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$311K Sell
7,252
-130
-2% -$5.59K 0.01% 523
2025
Q4
$324K Buy
7,382
+1,245
+20% +$51.5K 0.01% 481
2025
Q3
$253K Sell
6,137
-234
-4% -$9.4K 0.01% 554
2025
Q2
$281K Buy
+6,371
New +$255K 0.01% 462

Other funds holding EXEL

Journey Strategic Wealth's EXEL Position: Q1 2026 in Review

Journey Strategic Wealth reduced its Exelixis (EXEL) stake by 1.8% in Q1 2026, selling an estimated $5.59K and leaving 7,252 shares worth $311K. The position accounts for 0.01% of the portfolio, ranked #523.

Journey Strategic Wealth first reported a position in EXEL in Q2 2025 and has held it in 4 quarters since. The position peaked at $324K in Q4 2025. 701 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Journey Strategic Wealth held 7,252 shares of Exelixis worth $311K as of Q1 2026.
  • Journey Strategic Wealth sold 130 Exelixis shares in Q1 2026, an estimated $5.59K.
  • Exelixis made up 0.01% of Journey Strategic Wealth's portfolio in Q1 2026, its #523 holding.
  • Journey Strategic Wealth first reported a position in Exelixis in Q2 2025 and has held it in 4 quarters since.
  • Journey Strategic Wealth's Exelixis position peaked at $324K in Q4 2025.
  • 701 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.